| Health / Medical Topics |
Amsterdam Criteria II
Additional criteria for defining Hereditary Non-Polyposis Colorectal Cancer (HNPCC) families designed to accommodate the range of cancers that can be present in HNPCC families: 1. There should be at least 3 relatives with an HNPCC-associated cancer (colorectal cancer, cancer of the endometrium, small bowel, ureter, or renal pelvis); 2. One should be a first-degree relative of the other 2; 3. At least 2 successive generations should be affected; 4. At least 1 should be diagnosed before age 50; 5. Familial adenomatous polyposis should be excluded in the colorectal cancer cases; 6. Tumors should be verified by pathological examination. (NCI Thesaurus)
YOU MAY ALSO LIKE
Research criteria established for defining Hereditary Non-Polyposis Colorectal Cancer (HNPCC) families as established by the International Collaborative Group (ICG) meeting in Amsterdam…
A retinobenzoic acid with potential antineoplastic activity. Amsilarotene inhibits retinoblastoma-gene product (RB) phosphorylation and increases the presence of 2 cyclin-dependent kinase (CDK)…
Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain…
The lactate form of amsacrine, an aminoacridine analog and topoisomerase II inhibitor, with antineoplastic activity. Although the exact relationship between DNA binding…
An anticancer drug that belongs to the family of drugs called topoisomerase inhibitors.
The hydrochloride salt of a third-generation synthetic 9-amino-anthracycline with antineoplastic activity. Amrubicin intercalates into DNA and inhibits the activity of topoisomerase II,…
